Skip to main content

Addiction Medicine

Science and Practice

  • 2nd Edition - December 12, 2019
  • Latest edition
  • Author: Bankole Johnson
  • Language: English

Integrating scientific knowledge with today’s most effective treatment options, Addiction Medicine: Science and Practice, 2nd Edition, provides a wealth of information on addiction… Read more

Purchase options

Description

Integrating scientific knowledge with today’s most effective treatment options, Addiction Medicine: Science and Practice, 2nd Edition, provides a wealth of information on addictions to substances and behavioral addictions. It discusses the concrete research on how the brain and body are affected by addictions, improving your understanding of how patients develop addictions and how best to personalize treatment and improve outcomes. This essential text is ideal for anyone who deals with patients with addictions in clinical practice, including psychiatrists, health psychologists, pharmacologists, social workers, drug counselors, trainees, and general physicians/family practitioners.

Key features

  • Clearly explains the role of brain function in drug taking and other habit-forming behaviors, and shows how to apply this biobehavioral framework to the delivery of evidence-based treatment.
  • Provides clinically relevant details on not only traditional sources of addiction such as cocaine, opiates, and alcohol, but also more recently recognized substances of abuse (e.g., steroids, inhalants) as well as behavioral addictions (e.g., binge eating, compulsive gambling, hoarding).
  • Discusses current behavioral and medical therapies in depth, while also addressing social contexts that may affect personalized treatment.
  • Contains new information on compliance-enhancing interventions, cognitive behavioral treatments, behavioral management, and other psychosocial interventions.
  • Includes neurobiological, molecular, and behavioral theories of addiction, and includes a section on epigenetics.
  • Contains up-to-date information throughout, including a new definition of status epilepticus, a current overview of Lennox Gastaut syndrome, and updates on new FDA-approved drugs for pediatric neurological disorders.
  • Features expanded sections on evidence-based treatment options including pharmacotherapy, pharmacogenetics, and potential vaccines.
  • Addresses addiction in regards to specific populations, including adolescents, geriatric, pregnant women, and health care professionals.
  • Includes contributions from expert international authors, making this a truly global reference to addiction medicine.
  • Enhanced eBook version included with purchase.
  • Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

Readership

General Psychiatrist and Psychiatrist in Addiction Medicine.

Table of contents

Part I: History, Perspective, Epidemiology, Dx and Classification

1. Emerging Health Perspectives

2. The Epidemiology of Alcohol and Drug Disorders

3. United States Federal Drug Policy

4. Historical Perspectives of Addiction

5. Diagnosis and Classification of Substance Use Disorders
Part II: Behavioral Theories for Substance Use Disorder

6. Drug Reinforcement in Animals

7. Role of the Human Laboratory Studies in the Development of Medications for Alcohol and Substance Abuse Disorders

8. Conditioning of Addiction

9. Overlapping Striatal Circuits and Molecular Mechanisms in Rodent Models of Addiction and Depression

10. The Role of Endocannabinoids in Amphetamine-Driven Actions in Dopamine Neurons: Implications for Understanding and Treating Dysfunction in the Mesolimbic Circuit

11. Pain and Negative Affect

12. Genetic Vulnerability to Substance Use Disorders

13. Assessment and Treatment of Addiction in Best Practices and New Frontiers in a Direct to Consumer Age

14. Metabolomics in Drug Response and Addiction
Part III: Visualizations and Workings of the Addicted Brain

15. Visualization and Workings of the Addicted Brain

16. Neurobiological Basis of Drug Reward and Reinforcement

17. Neurobehavioral Toxicology of Substances of Abuse

18. Animal Models of Substance Use Disorders: Motivational Perspective

19. Novel Methodologies: Proteomic Approaches in Substance Abuse Research

20. Neuroinflammatory Processes in Drug Addiction
Part IV: Clinical Aspects of Alcohol and Drug Addiction

21. Alcohol: Clinical Aspects

22. Cocaine

23. Nicotine

24. Cannabis: An Overview of the Empirical Literature

25. Opiates and Prescription Drugs

26. Clinical Aspects of Methamphetamine

27. Sedative-Hypnotics and Anxiolytics

28. Clinical Aspects of Inhalant Addiction

29. Anabolic-Androgenic Steroids

30. Caffeine

31. Serotonergic Hallucinogens

32. Ketamine and Phencyclidine
Part V: Behavioral Addictions and Treatment

33. The Biology and Treatment of Pathological Gambling

34. Implications of "Food Addiction" for Understanding and Treating Binge Eating Disorder

35. Compulsive Buying

36. Sexual Behavior as an Addictive or Compulsive Phenomenon

37. New Era of Internet Addiction Research in China

38. Hoarding as a Behavioral Addiction
Part VI: Treatment and Application: Behavioral Treatments

39. Motivational Interviewing: Emerging Theory, Research, and Practice

40. Cognitive Behavioral Therapy for Addiction

41. Community Reinforcement Approach and Contingency Management Therapies

42. Relapse Prevention and Recycling in Addiction

43. Brief and e-Health Interventions for the Treatment of Alcohol or Other Drug Addiction

44. Self-Help Approaches for Addiction
Section VII: Treatment and Application: Group Treatments and Specific Settings

45. Community Clinics

46. Unhealthy Alcohol and Other Drug Use in Primary Care

47. Criminal Justice System and Addiction Treatment

48. Adolescent Neurocognitive Development and School-Based Drug Abuse Prevention and Treatment

49. The Therapeutic Community for Drug-Abuse Treatment: A Journey Yet Unfolding in the Recovery Movement

50. Substance Use-Focused Mutual-Help Groups: Processes and Outcomes
Section VIII: Treatment and Application Pharmacotherapy

51. Pharmacotherapy for Alcoholism and Some Related Psychiatric and Addictive Disorders: Scientific Basis and Clinical Findings

52. Alcohol Withdrawal: Treatment and Application

53. Pharmacotherapy of Cocaine Addiction

54. Opioid Overdose

55. Methamphetamine

56. Potential Pharmacotherapies for Cannabis Dependence

57. Hallucinogens
Section IX: Molecular Genetics, Alternative Therapies, and Other Topics in the Treatment of Addiction

58. Molecular Genetics and the Treatment of Addiction

59. Physical Considerations for Treatment Complications of Alcohol and Drug Use and Misuse

60. Quadruple Diagnosis: Substance Use Disorder, Comorbid Psychopathology, Human Immunodeficiency Virus Infection, and Hepatitis C Virus Infection

61. Substance Use Stigma as a Barrrier to Treatment and Recovery

62. Religiousness, Spirituality, and Addiction: An Evidence-Based Review
Section X: Computer Modeling

63. In Silico Models of Alcohol Kinetics: A Deterministic Approach

64. In Silico Models of Alcohol Dependence Treatment: Stochastic Approach

65. Dynamic and Systems-Based Models for Evaluating Hypotheses Related to Predicting Treatment Response
Part XI: Dependence in Specific Populations

66. Enhancing Positive Outcomes for Children of Substance-Abusing Parents

67. Alcohol and Substance Abuse in African Americans

68. Gays, Lesbians, and Bisexuals

69. Substance Use Disorders in Health Care Professionals

70. Identification and Treatment of Alcohol or Drug Dependence in the Elderly

71. Alcohol and Drugs of Abuse in Pregnant Women: Effects on Fetus and Newborn, Mode of Action, and Maternal Treatment
Part XII: Legal, Disability and Rehabilitative Issues

72. Forensic Issues

73. Disability and Addiction

74. The Homeless

75. To Open Up New Vistas in Basic and Preclinical Addiction Research

Review quotes

Doody's Core Titles® 2022

Product details

  • Edition: 2
  • Latest edition
  • Published: December 12, 2019
  • Language: English